Febuxostat Ethyl Ester CAS 160844-75-7 Purity >99.0% (HPLC) Febuxostat Intermediate Factory
Ruifu Chemical Supply Febuxostat Related Intermediates:
Febuxostat CAS 144060-53-7
Ethyl 2-Chloroacetoacetate CAS 609-15-4
4-Hydroxythiobenzamide CAS 25984-63-8
Ethyl 2-(3-Cyano-4-Hydroxyphenyl)-4-Methyl-1,3-thiazol-5-carboxylate CAS 161798-02-3
Ethyl 2-(3-cyano-4-isobutoksyfenyl)-4-methyl-5-thiazolcarboxylate CAS 160844-75-7
Ethyl 2-(3-Formyl-4-Hydroxyphenyl)-4-Methylthiazol-5-Carboxylate CAS 161798-01-2
Ethyl 2-(3-formyl-4-isobutoksyfenyl)-4-methylthiazol-5-carboxylate CAS 161798-03-4
Ethyl 2-(4-Hydroxyphenyl)-4-Methylthiazole-5-Carboxylate CAS 161797-99-5
Gemyske Namme | Etyl 2-(3-cyano-4-isobutoksyfenyl)-4-methyl-5-thiazolcarboxylate |
Synonimen | Febuxostat Ethyl Ester;Febuxostat Ethyl Ester ûnreinheid;Febuxostat ûnreinheid 15;Ethyl 2-(3-cyano-4-isobutoksyfenyl)-4-methylthiazol-5-carboxylate;2-(3-Cyano-4-Isobutoxyphenyl)-4-Methyl-5-Thiazolecarboxylic Acid Ethyl Ester |
CAS nûmer | 160844-75-7 |
CAT nûmer | RF-PI1857 |
Stock Status | Op foarried, produksjeskaal oant tonnen |
Molekulêre formule | C18H20N2O3S |
Molekuul gewicht | 344.43 |
Smeltpunt | 174,0 oant 178,0 ℃ |
Tichtheid | 1.22 |
Merk | It bedriuw Ruifu Chemical |
Ûnderdiel | Spesifikaasjes |
Ferskining | Wit of off-white poeder |
Identifikaasje | HPLC, NMR;LC-MS |
Related Substances | |
Yndividuele ûnreinheid | <0.50% |
Totaal ûnreinheden | <1.00% |
Ferlies op Drying | <0.50% |
Residu op Ignition | <0.20% |
Swiere metalen | <10ppm |
Purity / Analyse metoade | >99.0% (HPLC) |
Test Standert | Enterprise Standert |
Gebrûk | Intermediate of Febuxostat (CAS: 144060-53-7) |
Pakket: Fleske, aluminium folie tas, 25 kg / kartonnen trommel, of neffens klant syn eask
Opslach betingst:Bewarje yn fersegele konteners op in koel en droech plak;Beskermje fan ljocht en focht
Ethyl 2-(3-Cyano-4-Isobutoxyphenyl)-4-Methyl-5-thiazolecarboxylate (CAS: 160844-75-7) is in intermediate of ûnreinheid fan Febuxostat (CAS: 144060-53-7), in xanthine oxidase/ xanthine dehydrogenase inhibitor.Wurdt brûkt foar behanneling fan hyperurikemia en chronike jicht.40-120 mg / dei Febuxostat waard bewiisd effektyf yn it ferleegjen fan serum-urate-nivo's by administraasje om hyperurikemia te behearjen yn pasjinten mei jicht.